TNF and inflammatory bowel disease: Anti-tumor necrosis factor alpha (anti-TNF-α) agents were the first to be described and used as biologics for the treatment of IBD, but because of the complex pathophysiology of the disease, their efficacy has not been demonstrated in all patients [6].